Ms. Rosen is a partner in FBC's Corporate practice and leads the firm’s U.S. capital markets practice. Her practice focuses primarily on international capital markets, private and public M&A transactions, with an emphasis on cross-border transactions, and corporate governance advice. Ms. Rosen provides ongoing corporate and securities law advice to Israeli companies publicly traded in the United States as well as dual-listed companies.
Prior to joining FBC, Ms. Rosen was an associate in the Corporate and Securities department of a prominent law firm in New York and was a member of its Israeli Practice Group, representing Israeli NASDAQ-listed companies on their U.S. securities law compliance and public and private debt and equity offerings.
Hi-Tech, Technology & Venture Capital
New York, 2005
Hebrew University of Jerusalem, LL.B., 1996
Mega deal right out of the gate in 2022! We are excited to share that our firm has had the honor of representing our long-standing client, Tower Semiconductor Ltd., the Israeli chipmaker, in its acquisition by Intel, at a value of $5.4 billion (!) This deal is one of ...Avraham Well & Sharon Rosen & Ron Sitton & Yuval Peled & Tal Eyal-Boger & Ziv Schwartz & Moran Friedman & Etti Dolev & Omri Rachum-Twaig, Dr. & Audrey Abensur & Yahel Arckens | Mar 2022
בעדכון לקוחות זה נביא בפניכם פסק דין חשוב שניתן על ידי בית המשפט המחוזי בתל אביב (המחלקה הכלכלית), במסגרת בקשה לדיון חוזר על ההחלטה לאשר תובענה ייצוגית בפרשת סרגון נטוורקס נ' חזן, אשר קובע לראשונה הסדר גורף הנוגע לכלל החברות הדואליות ונושאי המשרה בהן, ומחיל דין אחד הן ל...Avraham Well & Gil Orion, Dr. & Sharon Rosen & Michal Sela | Feb 2022
Representation of Bank Mizrahi Tefahot, Israel’s third largest bank, in an international offering of US$600 million of its 3.077% Tier 2 Subordinated Notes due 2031. The Notes were offered to qualified institutional investors pursuant pursuant to Rule 144A of the Secur...Sharon Rosen & Avraham Well | Oct 2021
Representation of XT Investments Ltd. as a selling shareholder in the NIS 281M initial public offering in Israel and international offering of Terminal X Online Limited. Terminal X is Israel’s leading online fashion retailer. The initial public offering of Terminal X...Sharon Rosen & Vered Oren & Shmulik Fried & Anat Shavit | Oct 2021
Represented of Check-Cap Ltd. in a $35 million registered direct offering of ordinary shares and warrants. H.C. Wainwright & Co., LLC served as exclusive placement agent for the offering. Check-Cap, listed on NASDAQ, is a clinical stage medical diagnostics com...Eran Yaniv & Sharon Rosen & Anat Shavit | Oct 2021
Representation of ICL Group, a leading global specialty minerals and specialty chemicals company, in a private placement offering of its 6.375% senior unsecured notes due 2038 to a qualified institutional buyer pursuant to Rule 144A under the Securities Act of 1933, for...Sharon Rosen | Jan 2021
Representation of Check-Cap Ltd. in a warrant exercise transaction with several existing institutional investors who were holders of certain outstanding warrants to purchase the Company’s ordinary shares issued in prior registered direct offerings. In connection with...Eran Yaniv & Sharon Rosen & Anat Shavit & Yuval Peled | Jan 2021
Representation of J.P. Morgan as Lead Left Bookrunner and representative of the initial purchasers in the private offering by Fiverr International Ltd. (Nasdaq: FVRR) of $460 million of 0% Convertible Senior Notes due 2025 (including the exercise in full of the overallo...Eran Yaniv & Sharon Rosen & Anat Shavit & Yuval Peled & Omri Rachum-Twaig, Dr. & Gal Doitch | Jan 2021
Representation of J.P. Morgan, Bank of America and Morgan Stanley as Joint Book-Running Managers in the private offering by Wix.com Ltd. (Nasdaq: WIX) of $575 million of 0% Convertible Senior Notes due 2025 (including the exercise in full of an over-allotment option gra...Michael Zellermayer & Sharon Rosen & Anat Shavit & Yuval Peled | Oct 2020
Representation of Kitov Pharma Ltd. in a US$35M registered direct offering of shares represented by American Depositary Shares (ADSs) and warrants to purchase ADSs. H.C. Wainwright & Co., LLC acted as exclusive placement agent for the offering. Kitov Pharma Lt...Raz Tepper & Sharon Rosen | Sep 2020